Conquering Diseases

Study for Triple Negative Breast Cancer Patients Who Have Undergone Chemotherapy Prior to Surgery

Description

The study is open to men & women with triple negative breast cancer that have received chemotherapy prior to surgery, then had surgery to remove the breast cancer, and viable tumor was still seen in the surgery specimen.

Overview

The main purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum based chemotherapy (cisplatin or carboplatin), after surgery.

What we're hoping for

We are hoping that a platinum-based chemotherapy after surgery could prevent the cancer from returning (metastatic recurrence)

Additional Information

ClinicalTrials.gov Identifier: NCT02445391

 Principal Investigator

Kathryn  Edmiston, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989